04:46:29 EDT Sun 29 Mar 2026
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News last 24 hour(s) - 25 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2026-03-28 22:07U:SKTCFNews ReleaseSkychain Technologies Inc. Provides Update on Financial Position, Asset Status, and Ongoing Transition Issues
2026-03-28 20:20U:ELEKNews ReleaseWhere Speed Meets Opportunity - a New Era in Electric Mobility Begins
2026-03-28 16:45U:AMGNNews ReleaseREPATHA(TM) CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS
2026-03-28 15:15U:LLYNews ReleasePhase 3b data presented at AAD Annual Meeting show Lilly's Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with psoriatic arthritis and obesity
2026-03-28 15:00U:TAKNews ReleaseTakeda's Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care
2026-03-28 15:00U:ROIVNews ReleaseNew England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis
2026-03-28 15:00U:MLTXNews ReleaseMoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting
2026-03-28 15:00U:INCYNews ReleaseIncyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting
2026-03-28 15:00U:BIIBNews ReleaseBiogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity
2026-03-28 14:45U:CORTNews ReleaseCorcept Presents Data from MOMENTUM Trial at American College of Cardiology Annual Scientific Session
2026-03-28 13:30U:ALMSNews ReleaseAlumis' Envudeucitinib Delivers Early and Robust Improvements in Skin Clearance, Quality of Life and Psoriasis Symptoms in Two Phase 3 Trials, Underscoring Its Potential as a Leading Oral Therapy for Plaque Psoriasis
2026-03-28 12:36U:NKTRNews ReleaseData from Phase 2b REZOLVE-AD and REZOLVE-AA Studies of Rezpegaldesleukin Presented at 2026 American Academy of Dermatology Annual Meeting
2026-03-28 11:00U:KYMRNews ReleaseKymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting
2026-03-28 11:00U:ARQTNews ReleaseArcutis Presents New Phase 2 Results in Infants with Atopic Dermatitis in Late-Breaking Session Today at the 2026 American Academy of Dermatology Annual Meeting
2026-03-28 10:55U:BSXNews ReleaseCHAMPION-AF study of the WATCHMAN FLX(TM) Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpoints
2026-03-28 10:38U:BSXNews ReleaseHI-PEITHO trial demonstrates Boston Scientific EKOS(TM) Endovascular System is superior to standard of care for treatment of acute pulmonary embolism
2026-03-28 10:30U:ARWRNews ReleaseArrowhead Pharmaceuticals Presents New Long-Term Efficacy and Safety Data for Plozasiran Across a Spectrum of Hypertriglyceridemia at the American College of Cardiology's 75th Annual Scientific Session and Expo
2026-03-28 10:05U:PTGXNews ReleaseProtagonist Announces Presentation of One-Year Phase 3 Data for ICOTYDE(TM) in Moderate-to-Severe Plaque Psoriasis at the 2026 American Academy of Dermatology (AAD) Annual Meeting
2026-03-28 10:00U:JNJNews ReleaseICOTYDE(TM) (icotrokinra) one-year results confirm lasting skin clearance and favorable safety profile in once-daily pill for plaque psoriasis
2026-03-28 07:00U:VNews ReleaseVisa, Street Soccer USA and Bank of America to Bring Visa Street Soccer Parks to Every FIFA World Cup 2026(TM) Host City in the U.S.
2026-03-28 07:00U:VNews ReleaseVisa, Street Soccer USA and Bank of America to Bring Visa Street Soccer Parks to Every FIFA World Cup 2026(TM) Host City in the U.S.
2026-03-28 07:00U:BMYNews ReleaseOpen Label Outpatient Switch Study Demonstrates Symptom Stability During Transition from Oral Atypical Antipsychotics to Cobenfy(TM) (xanomeline and trospium chloride)
2026-03-28 07:00U:BACNews ReleaseVisa, Street Soccer USA and Bank of America to Bring Visa Street Soccer Parks to Every FIFA World Cup 2026(TM) Host City in the U.S.
2026-03-28 07:00U:BACNews ReleaseVisa, Street Soccer USA and Bank of America to Bring Visa Street Soccer Parks to Every FIFA World Cup 2026(TM) Host City in the U.S.
2026-03-28 06:40U:RKLBNews ReleaseRocket Lab Successfully Launches 85th Mission and First Dedicated Launch for European Space Agency